HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew J Barker Selected Research

Gefitinib (Iressa)

10/2002ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew J Barker Research Topics

Disease

2Neoplasms (Cancer)
12/2008 - 10/2002
1Neoplasm Metastasis (Metastasis)
10/2002

Drug/Important Bio-Agent (IBA)

1imidazoleIBA
12/2008
1AmidesIBA
12/2008
1pyrimidineIBA
12/2008
1AZD5597IBA
12/2008
1anilinoquinazolineIBA
10/2002
1ErbB Receptors (EGF Receptor)IBA
10/2002
1Gefitinib (Iressa)FDA Link
10/2002
1Epidermal Growth Factor (EGF)IBA
10/2002

Therapy/Procedure

1Radiotherapy
10/2002
1Therapeutics
10/2002
1Drug Therapy (Chemotherapy)
10/2002